AI Automation for Pharmacovigilance in Pharma and Life Sciences

AI automation for pharmacovigilance in pharma and life sciences demonstrates end-to-end case intake, coding, literature checks, and signal escalation with auditable human review and compliant traceability throughout the lifecycle.

By Suhas Bhairav · Updated

Direct Answer

AI automation for pharmacovigilance in pharma and life sciences means automating case intake, data extraction, adverse event coding, literature and regulatory signal checks, and escalation workflows while preserving reviewer accountability, traceability, and decision records for compliance and quality control across regulatory timelines and audit trails.

Best for: Pharmacovigilance managers, safety scientists, and regulatory affairs specialists.

What You Can Automate in Pharmacovigilance in Pharma and Life Sciences

  • Case intake

    Automatically capture reports from medical letters, emails, E2B submissions, and chat channels; extract patient, event, drug, dose, and reporter details into structured fields; normalize data types and time stamps into a unified case template for downstream processing.

  • Data extraction

    Parse narratives into standardized fields; map to MedDRA, WHODrug, and SNOMED vocabularies; normalize dates, severities, outcomes, reporter roles, and exposure duration for consistent record integration.

  • Adverse event coding

    Assign MedDRA terms, SOCs, and preferred terms; validate against exposure data, flag ambiguities for reviewer intervention; maintain a full coding audit trail with versioning and change history.

  • Literature checks

    Execute periodic, targeted searches of biomedical databases and journals; extract safety signals, study design notes, and relevance rankings; summarize findings for reviewer input and regulatory consideration.

  • Signal detection

    Merge internal case data with external databases; apply rule-based filters and lightweight ML models to surface potential signals; generate priority scores and flag documentation gaps.

  • Escalation workflow

    Route high-priority cases to safety leads; produce notifications with deadlines, required reviewer actions, and escalation paths; update case status and ensure regulatory timelines are tracked.

How It Works

  1. trigger

    A new safety report enters the intake portal, email, or API, initiating automated parsing, validation, and initial risk indication scoring against predefined criteria.

  2. gather data

    System aggregates patient demographics, exposure details, event terms, seriousness, onset, reporter type, and country; cross-references with internal registries and prior reports for duplicates.

  3. AI decision

    AI assigns preliminary MedDRA terms, performs data quality assessments, detects missing fields, and flags inconsistent entries or high-risk events for expedited human review.

  4. action in system

    Structured case records are created in the pharmacovigilance database; coding, literature checks, and signal flags populate the case file with traceable timestamps and versioned changes.

  5. human review

    A safety scientist validates terminology, reconciles discrepancies, approves final coding, and determines next actions within regulatory timelines, documenting rationale and any deviations.

Worked Example

Rerouting a high-priority ADR case

Illustrative scenario with sample data.

Scenario

A multinational pharma firm receives a spontaneous ADR report from a hospital; the event appears serious, involves a drug with prior safety signals, and requires expedited review to determine regulatory reporting needs.

Input

case_id=PKV-4921; report_source=hospital; patient_age=62; patient_gender=F; drug=DrugX; event=Chronic liver injury; onset=3 weeks; seriousness=Serious; reporter_type=physician; medication_start=2026-09-15; narrative=“patient developed elevated liver enzymes after DrugX initiation; no alternative causes identified.”; country=US; date_received=2026-10-02; concomitant_medications=None; prior_signals=Yes; exposure_duration=21 days.

What the automation does

  1. System ingests the report and extracts fields into the case record; mapping aligns demographics, exposure, and event terms to standard vocabularies.
  2. AI assigns MedDRA terms, checks for duplicates, and flags potential liver injury signal for safety review.
  3. Safety reviewer examines coding, verifies temporal association, reviews literature hints, and approves escalation if criteria meet regulatory thresholds.
  4. Case is routed to regulatory affairs with initial assessment, required actions, and a documented escalation path.

Output

case_id=PKV-4921; status=Escalated; MedDRA_terms=Chronic liver injury, Drug-induced liver injury; signal_flags=High priority; action_required=Expedited safety review; assigned_to=EuropeSafetyLead; date_assessed=2026-10-03; follow_up=Regulatory reporting due, update case file.

Human decision

The safety scientist confirms preferred MedDRA terms, validates temporal relation, ensures no alternative etiology, and approves escalation to regulatory for potential safety signal and required regulatory reporting with documented justification.

What You Need

  • Structured intake data fields from forms, emails, and E2B submissions
  • Access to safety database and audit-enabled coding tools
  • Standard vocabularies: MedDRA, SNOMED, WHO Drug Reference List
  • User roles and permissions for review, escalation, and reporting actions

Where People Stay in Charge

  • Decisions on whether a case represents a reportable safety signal require human judgment and regulatory assessment based on context and prior knowledge.
  • Reasoning for complex drug-event relationships must be reviewed by a Pharmacovigilance lead before final coding is published to ensure regulatory alignment.
  • Discrepancies between data sources or coding terms require human reconciliation with a documented rationale within the case file.

FAQ

What tasks can be automated in pharmacovigilance workflow?

Automatable tasks include case intake, data extraction, coding of adverse events, literature checks for safety signals, automated signal detection, and escalation workflows. Human review remains essential for final decisions, regulatory alignment, and complex judgment calls within governed processes.

How does automated coding work for adverse events?

Automated coding maps narratives to standard terms (MedDRA) and checks for consistency with exposure data; it flags ambiguities and routes them to a human reviewer for confirmation before finalizing the record, with an audit trail.

Can automation handle regulatory reporting deadlines?

Yes, automation flags deadlines, assembles required fields, and routes cases to the proper regulatory team for timely submission, while preserving an auditable trail of all actions and changes.

What safeguards ensure data quality and traceability?

Every automated action creates a traceable log, changes are versioned, and human reviews are required for final approvals to maintain compliance and data integrity across the case file.